HIPEC and Peritoneal Spread: A “New” Opportunity for Cure

fsd

Colorectal Cancer in 2017: Course 5 of 9

Peritoneal metastasis is the sole site in 20-25% of colon rectal cancer.  Peritoneal metastasis is the second leading cause of colon rectal cancer.  This presentation discusses the types of patients  and where in the overall treatment plan patients benefit from colon rectal surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).  The future implications for HIPEC are also discussed.

Total Viewing Time: 25 minutes - 1 video
Instruction Format: Slide and Presentation On Demand Webinar
Cost: Complimentary
Credit: 0.25 AMA PRA Category 1 Credits™ (Internet Enduring Material)